한국임상수의학회지 (Journal of Veterinary Clinics)

  • 제38권1호
  • /
  • Pages.21-26
  • /
  • 2021
  • /
  • 1598-298X(pISSN)
  • /
  • 2384-0749(eISSN)
한국임상수의학회 (The Korean Society of Veterinary Clinics)
권호 표지
DOI QR코드

DOI QR Code

Comparative Proteomic Profile of Canine Uterus with Pyometra

  • Ahn, Soomin (College of Veterinary Medicine, Gyeongsang National University) ;
  • Saralamma, Venu Venkatarame Gowda (Research Institute of Life science and College of Veterinary Medicine, Gyeongsang National University) ;
  • Vetrivel, Preethi (Research Institute of Life science and College of Veterinary Medicine, Gyeongsang National University) ;
  • Han, Hyun-Jung (Department of Veterinary Emergency and Critical Care Medicine, Konkuk Veterinary Medical Teaching Hospital, Konkuk University) ;
  • Park, Jinho (College of Veterinary Medicine, Jeonbuk National University) ;
  • Jung, Dong-In (College of Veterinary Medicine, Gyeongsang National University) ;
  • Kim, Gon Sup (Research Institute of Life science and College of Veterinary Medicine, Gyeongsang National University) ;
  • Yu, DoHyeon (College of Veterinary Medicine, Gyeongsang National University)
  • 투고 : 2020.09.23
  • 심사 : 2021.01.20
  • 발행 : 2021.02.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Pyometra, a common disorder in intact bitches, can lead to canine sepsis. Identification of biomarkers for sources of infection in the uterus using two-dimensional electrophoresis (2-DE)-mass spectrometry (MS) analysis may enable the discovery of novel diagnostic markers of sepsis. Toward this end, surgically resected uterus samples from four bitches (three pyometra and one healthy) were randomly selected for 2-DE-MS, which identified 32 differentially expressed proteins, including seven inflammatory proteins, five non-inflammatory proteins, and 20 functionally unknown proteins. Despite the limited information on canine uterus proteomics, we suggest the potential use of differentially expressed uterus proteins as candidate biomarkers to discover targets to attenuate inflammation in pyometra. Further identification of the functionally unknown proteins is warranted.

키워드

참고문헌

  1. Bukowska D, Kempisty B, Zawierucha P, Jopek K, Piotrwoska H, Antosik P, Cieslolka S, Wozna M, Brüssow KP, Jaskowski JM. Microarray analysis of inflammatory response-related gene expression in the uteri of dogs with pyometra. J Biol Regul Homeost Agents 2013; 28: 637-648.
  2. Chen Y, Zhang H, Zu A, Li N, Liu J, Liu C, Lv D, Wu S, Huang L, Yang S, He D, Xiao X. Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer. Lung Cancer 2006; 54: 95-102. https://doi.org/10.1016/j.lungcan.2006.06.014
  3. Conti-Patara A, de Araujo Calderia J, de Mattos-Junior E, de Carvalho Hda S, Reinoldes A, Pedron BG, Patara M, Francisco Talib MS, Faustino M, de Oliveira CM, Cortopassi SR. Changes in tissue perfusion parameters in dogs with severe sepsis/septic shock in response to goal-directed hemodynamic optimization at admission to ICU and the relation to outcome. J Vet Emerg Crit Care 2012; 22: 409-418. https://doi.org/10.1111/j.1476-4431.2012.00769.x
  4. Egenvall A, Hagman R, Bonnett BN, Hedhammer A, Olson P, Lagerstedt AS. Breed risk of pyometra in insured dogs in Sweden. J Vet Intern Med 2001;15: 530-538. https://doi.org/10.1892/0891-6640(2001)015<0530:BROPII>2.3.CO;2
  5. Fransson BA, Lagerstedt AS, Bergstrom A, Hagman R, Park JS, Chew BP, Evans MA, Ragle CA. C-reactive protein, tumor necrosis factor α, and interleukin-6 in dogs with pyometra and SIRS. J Vet Emerg Crit Care 2007; 17: 373-381. https://doi.org/10.1111/j.1476-4431.2006.00203.x
  6. Gibson DS, Newell K, Evans AN, Finnegan S, Manning G, Scaife C, McAllister C, Pennington SR, Duncan MW, Moore TL, Rooney ME. Vitamin D binding protein isoforms as candidate predictors of disease extension in childhood arthritis. J Proteomics 2012; 75: 5479-5492. https://doi.org/10.1016/j.jprot.2012.06.024
  7. Graves PR, Haystead TA. Molecular biologist's guide to proteomics. Microbiol Mol Biol Rev 2002; 66: 39-63. https://doi.org/10.1128/MMBR.66.1.39-63.2002
  8. Hagman R, Lagerstedt AS, Hedhammar A, Egenvall A. A breed-matched case-control study of potential risk-factors for canine pyometra. Theriogenology 2011; 75: 1251-1257. https://doi.org/10.1016/j.theriogenology.2010.11.038
  9. Hagman R, Ronnberg E, Pejler G. Canine uterine bacterial infection induces upregulation of proteolysis-related genes and downregulation of homeobox and zinc finger factors. PLOS ONE 2009; 4: e8039. https://doi.org/10.1371/journal.pone.0008039
  10. Holbrook JJ, Liljas A, Steindel SJ, Rossmann MG. 4 lactate dehydrogenase. In: The Enzymes No. 11. Academic Press, New York: Boyer PD. 1975: 191-292.
  11. Kanda S, Mochizuki Y, Miyata Y, Kanetake H, Yamamoto N. Effects of vitamin D(3)-binding protein-derived macrophage activating factor (GcMAF) on angiogenesis. J Natl Cancer Inst 2002; 94: 1311-1319. https://doi.org/10.1093/jnci/94.17.1311
  12. Koukourakis MI, Giatromanolaki A, Simopoulos C, Polychronidis A, Sivridis E. Lactate dehydrogenase 5 (LDH5) relates to upregulated hypoxia inducible factor pathway and metastasis in colorectal cancer. Clin Exp Metastasis 2005; 22: 25-30. https://doi.org/10.1007/s10585-005-2343-7
  13. Lee HJ, Venkatarame Gowda Saralamma V, Kim SM, Ha SE, Vetrivel P, Kim EH, Lee SJ, Heo JD, Rampogu S, Lee KW, Kim GS. Comparative proteomic profiling of tumor-associated proteins in human gastric cancer cells treated with pectolinarigenin. Nutrients 2018; 10: E1596.
  14. Leviton A, Allred EN, Fichorova RN, VanderVeen DK, O'Shea TM, Kuban K, Dammann O, ELGAN Study Investigators. Early postnatal IGF-1 and IGFBP-1 blood levels in extremely preterm infants: Relationships with indicators of placental insufficiency and with systemic inflammation. Am J Perinatol 2019; 36: 1442-1452. https://doi.org/10.1055/s-0038-1677472
  15. Nagappan A, Park HS, Park KI, Hong GE, Yumnam S, Lee HJ, Kim MK, Kim EH, Lee WS, Lee WJ, Cho MJ, Lee WK, Won CK, Cho JH, Kim GS. Helicobacter pylori infection combined with DENA revealed altered expression of p53 and 14-3-3 isoforms in Gulo-/- mice. Chem Biol Interact 2013; 206: 143-152. https://doi.org/10.1016/j.cbi.2013.09.002
  16. Nagappan A, Venkatarame Gowda Saralamma V, Hong GE, Lee HJ, Sin SC, Kim EH, Lee WS, Kim GS. Proteomic analysis of selective cytotoxic anticancer properties of flavonoids isolated from Citrus platymamma on A549 human lung cancer cells. Mol Med Rep 2016; 14: 3814-3822. https://doi.org/10.3892/mmr.2016.5666
  17. Pan C, Xing JH, Zhang C, Zhang YM, Zhang LT, Wei SJ, Zhang MX, Wang XP, Yuan QH, Xue L, Wang JL, Cui ZQ, Zhang Y, Xu F, Chen YG. Aldehyde dehydrogenase 2 inhibits inflammatory response and regulates atherosclerotic plaque. Oncotarget 2016; 7: 35562-35576. https://doi.org/10.18632/oncotarget.9384
  18. Pang J, Peng H, Wang S, Xu X, Xu F, Wang Q, Chen Y, Zhang Y, Ren J. Mitochondrial ALDH2 protects against lipopolysaccharide-induced myocardial contractile dysfunction by suppression of ER stress and autophagy. Biochim Biophys Acta Mol Basis Dis 2019; 1865: 1627-1641. https://doi.org/10.1016/j.bbadis.2019.03.015
  19. Voorwald FA, Marchi FA, Villacis RA, Alves CE, Toniollo GH, Amorim RL, Drigo SA, Rogatto SR. Molecular expression profile reveals potential biomarkers and therapeutic targets in canine endometrial lesions. PLOS ONE 2015; 10: e0133894. https://doi.org/10.1371/journal.pone.0133894
  20. Zhang C, Wang YE, Zhang P, Liu F, Sung CJ, Steinhoff MM, Quddus MR, Lawrence WD. Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma. Hum Pathol 2010; 41: 255-261. https://doi.org/10.1016/j.humpath.2009.07.019
  21. Zhang J, Habiel DM, Ramadass M, Kew RR. Identification of two distinct cell binding sequences in the vitamin D binding protein. Biochim Biophys Acta 2010; 1803: 623-629. https://doi.org/10.1016/j.bbamcr.2010.02.010
  22. Zhang Y, Ren J. ALDH2 in alcoholic heart diseases: molecular mechanism and clinical implications. Pharmacol Therapeut 2011; 132: 86-95. https://doi.org/10.1016/j.pharmthera.2011.05.008